Critical Insulin Dosing Error Requiring Immediate Correction
This patient is severely underdosed on insulin due to an incorrect conversion from 100 IU/mL to 40 IU/mL concentration, resulting in uncontrolled hyperglycemia (RBS 256 mg/dL) with concerning vital signs including tachycardia (126 bpm) and hypertension (150/100 mmHg).
Immediate Insulin Dose Correction
The patient's current insulin regimen is dangerously inadequate. When she was taking Mixtard 30/70 100 IU/mL (18 units morning, 12 units evening = 30 total daily units), she was receiving the correct dose. However, when switched to Mixtard 30/70 40 IU/mL, she should have been instructed to draw 2.5 times the volume to maintain the same insulin dose, not reduce her units 1.
Correct conversion:
- Morning: Should be drawing 45 units of 40 IU/mL (equivalent to 18 units of 100 IU/mL)
- Evening: Should be drawing 30 units of 40 IU/mL (equivalent to 12 units of 100 IU/mL)
- Currently taking only 20 morning/10 evening = receiving only 40% of her required insulin dose
Systematic Approach to This Case
1. Assess for Acute Complications
Evaluate for diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state given the significant hyperglycemia 2, 3:
- Check serum ketones (beta-hydroxybutyrate preferred) or urine ketones
- Venous blood gas for pH and bicarbonate
- Serum electrolytes (sodium, potassium, chloride)
- Calculate anion gap
- Check serum osmolality
- Assess hydration status
Her RBS of 256 mg/dL places her in Grade 2 hyperglycemia category (160-250 mg/dL), which requires urgent intervention but likely not hospitalization if no ketoacidosis is present 4.
2. Evaluate Contributing Factors to Current Presentation
The tachycardia (126 bpm) and hypertension (150/100 mmHg) may represent:
- Sympathetic response to hyperglycemia
- Dehydration from osmotic diuresis
- Underlying infection or illness (check for fever, urinary symptoms, respiratory symptoms)
- Cardiovascular complications of long-standing diabetes
Key investigations:
- Complete blood count (infection)
- Renal function (creatinine, eGFR) - insulin requirements may be altered in renal impairment 1
- Liver function tests
- Urinalysis and urine culture
- ECG (given tachycardia and hypertension)
- HbA1c to assess chronic control
3. Correct the Insulin Regimen Immediately
Option A - Continue with 40 IU/mL concentration (if this is what's available):
- Morning: 45 units of Mixtard 30/70 40 IU/mL
- Evening: 30 units of Mixtard 30/70 40 IU/mL
- Provide clear written instructions with visual aids showing the correct syringe markings
Option B - Switch back to 100 IU/mL concentration (preferred to avoid confusion):
- Morning: 18 units of Mixtard 30/70 100 IU/mL
- Evening: 12 units of Mixtard 30/70 100 IU/mL
Given her current poor control, consider intensifying therapy 5, 6:
- Increase total daily dose by 10-20% (add 3-6 units total daily)
- Distribute as: Morning 20 units, Evening 14 units (if using 100 IU/mL)
- Or Morning 50 units, Evening 35 units (if using 40 IU/mL)
4. Patient Education - Critical to Prevent Recurrence
Insulin concentration education 1:
- Explain the difference between 100 IU/mL and 40 IU/mL concentrations
- Demonstrate proper syringe selection (U-100 syringes for 100 IU/mL, U-40 syringes for 40 IU/mL)
- Provide written conversion chart if she must use 40 IU/mL
- Emphasize never mixing insulin concentrations
Injection technique review 7, 8:
- Proper site rotation (abdomen, thighs, upper arms)
- Avoid lipohypertrophy areas
- Use new needles for each injection (needle reuse increases lipohypertrophy risk)
- Inject into subcutaneous tissue, not muscle
Self-monitoring blood glucose 9, 5:
- Check fasting glucose daily
- Check 2-hour post-meal glucose periodically
- Recognize symptoms of hypoglycemia and hyperglycemia
- Keep glucose tablets or juice available
5. Address Hypertension and Cardiovascular Risk
With BP 150/100 mmHg and 15-year diabetes duration, comprehensive cardiovascular risk reduction is essential 9:
- Initiate or optimize antihypertensive therapy (ACE inhibitor or ARB preferred in diabetes)
- Check lipid panel and consider statin therapy
- Assess for other diabetic complications (retinopathy, nephropathy, neuropathy)
6. Short-term Management Plan
Today/Day 1:
- Correct insulin dose immediately
- If ketones negative and patient stable: outpatient management acceptable
- If ketones positive or patient appears unwell: consider admission 2
- Provide supplemental short-acting insulin if RBS remains >250 mg/dL (4-6 units regular insulin subcutaneously)
Follow-up in 2-3 days:
- Review blood glucose logs
- Adjust insulin doses based on fasting glucose patterns 10, 6
- Reassess vital signs
Follow-up in 1-2 weeks:
- Comprehensive diabetes review
- Review all investigation results
- Optimize other medications
7. Consider Transition to Modern Insulin Regimen
Given 15 years of diabetes and current poor control on premixed insulin, consider 5, 6:
- Basal-bolus regimen with long-acting basal insulin (glargine, detemir, or degludec) plus rapid-acting mealtime insulin
- This provides more flexibility and better glycemic control
- Long-acting analogues have lower hypoglycemia risk than NPH 5, 10
Common Pitfall: Premixed insulins like Mixtard 30/70 require consistent meal timing and carbohydrate intake. If the patient has irregular eating patterns, a basal-bolus regimen would be superior 9, 5.
8. Glycemic Targets
For this 52-year-old with 15-year diabetes duration 9, 5:
- Fasting glucose: 80-130 mg/dL (4.4-7.2 mmol/L)
- 2-hour postprandial: <180 mg/dL (<10 mmol/L)
- HbA1c: <7% (individualize based on hypoglycemia risk, comorbidities)
The fundamental issue here is a medication error in insulin concentration conversion that has resulted in the patient receiving less than half her required insulin dose for one month, leading to symptomatic hyperglycemia. Immediate correction of the insulin dose with comprehensive patient education is the priority, followed by systematic evaluation for complications and optimization of overall diabetes management 1.